Share on :

Asset Summary

Weekly Performance Report for BIB ETF: Week 46, 2024

Summary: The Weekly started with BIB ETF opening at $67.18 and closing at $53.66. The ETF showed weakness throughout the Weekly, with the highest price observed at $68 and the lowest at $53.5. The underlying asset had a trading range of $14.50 Overall, it was a negative trading Weekly for BIB ETF, reflecting investor pessimism and market activity.

Change in Closing Price: There was a net decrease of $-13.52 or -20.13% in the closing price from the opening to the closing price over the Weekly.

Volume Analysis: Trading volume for BIB ETF was 112,812 units during Week 46, indicating active market participation and investor interest.

Opening Price: The Weekly started at $67.18.

Highest Price: The highest price observed during the Weekly was $68.

Lowest Price: The lowest price observed during the Weekly was $53.5.

Closing Price: The Weekly ended at $53.66.

Asset Performance Metrics and Risk Characteristics:

Understanding asset performance is crucial for evaluating investment quality and making informed decisions. Metrics like trailing return and drawdown provide insights into how an asset has performed over time, its volatility, and the efficiency of its returns relative to risk. Performance indicators help assess the stability, risk, and reward of an investment, allowing investors and portfolio managers to make comparisons and strategize accordingly.

Asset Technical Analysis

Technical analysis involves evaluating an asset's price and volume data to forecast future movements and make informed trading decisions. By using various technical indicators and chart patterns, investors can gain insights into market trends, price momentum, and potential turning points. This section delves into essential technical metrics, including moving averages, pivot points, and other indicators that provide a snapshot of an asset's current technical stance. Analyzing these indicators helps investors identify entry and exit points, assess market sentiment, and refine their trading strategies. Explore the following technical analysis data to understand the asset's performance dynamics and make better-informed decisions.

Moving Averages

Moving Averages are commonly used to smooth out price data and identify trends over a specific period. Here’s a summary of the latest moving averages for various periods:

  • SMA (Simple Moving Average): Reflects the average price over a specific number of periods.
  • EMA (Exponential Moving Average): Gives more weight to recent prices, making it more responsive to new information.
  • WMA (Weighted Moving Average): Assigns a weight to each price, emphasizing more recent prices.
  • WEMA (Weighted Exponential Moving Average): Combines elements of both WMA and EMA for a more responsive moving average.

Advance Your BIB Trading Now

Take control of your trading with RankMyTrade Platform. Our platform offers unparalleled analysis and technical support for BIB, designed to enhance your market performance. Enhance your market performance today today and experience the difference with our expert tools!

Maximize Results Now

Frequently Asked Questions

Similar ETFs to BIB include: LABU (Direxion Daily S&P Biotech Bull 3X Shares), which seeks to provide three times the daily performance of the S&P Biotechnology Select Industry Index; IBB (iShares Nasdaq Biotechnology ETF), which tracks the Nasdaq Biotechnology Index and provides exposure to biotechnology and pharmaceutical companies; and XBI (SPDR S&P Biotech ETF), which tracks the S&P Biotechnology Select Industry Index and provides broad exposure to the biotech sector.

BIB rebalances its holdings daily to maintain its leverage ratio of 2x the daily performance of the S&P Biotechnology Select Industry Index. This daily rebalancing can lead to differences in performance over time compared to the index due to the effects of compounding.

BIB typically distributes dividends on a quarterly basis. These dividends are generated from income produced by the underlying securities in the ETF, though leveraged ETFs may have lower yield compared to non-leveraged funds.

BIB aims to deliver twice the daily return of the S&P Biotechnology Select Industry Index. However, due to its leveraged nature, performance can diverge significantly over longer periods due to compounding effects and daily rebalancing.

Yes, BIB can be held in retirement accounts such as IRAs or 401(k)s. However, due to its leveraged nature and higher risk profile, it’s important to consider how it fits within your overall investment strategy and risk tolerance.

Factors influencing BIB’s performance include movements in the biotechnology sector, changes in the S&P Biotechnology Select Industry Index, market volatility, and the effects of leverage. The ETF’s performance is also impacted by its daily rebalancing and compounding effects.

Historical performance data for BIB includes past returns, NAV, and volatility. Investors should review performance charts and reports to understand how BIB has tracked its leveraged objective over different time periods.

Investors can purchase shares of BIB through a brokerage account. It is traded on major stock exchanges under the ticker symbol "BIB" and can be bought and sold like other stocks and ETFs.

Risks include high volatility and the potential for substantial losses due to the leveraged nature of the ETF. BIB’s performance is highly sensitive to daily changes in the biotech sector, and its use of leverage can amplify both gains and losses.

BIB is managed by ProShares and seeks to achieve its investment objective by using financial instruments, including derivatives such as futures contracts, options, and swap agreements. It aims to provide leveraged exposure to the biotechnology sector.

Supercharge Your BIB Trading Now

Achieve superior trading results with RankMyTrade Online. Our platform provides expert analysis and actionable insights for BIB, utilizing the latest technology to refine your investment approach. Enhance your market performance today now and see the impact on your trading success!

Disclaimers

The information displayed on this site is sourced from third-party providers and is believed to be reliable. RankMyTrade (RMT) has not independently verified this data and does not guarantee its accuracy. The information and calculations provided by RankMyTrade are for educational and informational purposes only and should not be construed as financial or investment advice.

With any investment, your capital is at risk. The value of your portfolio go down as well as up. Past performance is no guarantee of future results. By using this website, you accept our Terms of Service, Privacy Policy, and Payment Agreement.

Market data is provided in near real-time when available, but we do not guarantee its accuracy or timeliness.

Securities products are: Not FDIC insured · Not bank guaranteed · May lose value

Trademarks and logos are the property of their respective owners and do not represent endorsements of any kind. Unless otherwise noted, RankMyTrade and its affiliates are not partners, affiliates, or licensees of these companies.

Supported Assets & ETFs